Publications by authors named "Matthew R Rowe"

Claim this Profile
T
The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.
Marie-Sophie Fabre, Nicole M Stanton, Tania L Slatter, Samuel Lee, Dinindu Senanayake, Matthew R Rowe

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Microtubule-Destabilizing Activity of N-Cyclopropyl-4-((3,4-dihydroquinolin-1(2H)-yl)sulfonyl)benzamide and its Analogs.
Jessica J Field, A Jonathan Singh, Saptarshi Sinha, Matthew R Rowe, William A Denny

Chem Asian J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Mitochondria in Health and Disease.
Patries M Herst, Matthew R Rowe, Georgia M Carson, Michael V Berridge

Front Endocrinol (Lausanne)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models.
Nicole M Jones, Matthew R Rowe, Peter R Shepherd, Melanie J McConnell

Int J Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
Arun Kanakkanthara, Matthew R Rowe, Jessica J Field, Peter T Northcote, Paul H Teesdale-Spittle

Cancer Lett· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis